Key Events This Week
30 Mar: Stock hits 52-week low at Rs.6.65 and all-time low at Rs.7.48
01 Apr: Sharp rebound with 9.49% gain to Rs.7.50
02 Apr: Continued rally with 10.00% gain to Rs.8.25
03 Apr: Week closes at Rs.8.25, up 12.70% for the week
30 March 2026: Stock Hits 52-Week and All-Time Lows Amid Prolonged Downtrend
On 30 March, Deccan Health Care Ltd’s shares reached a 52-week low of Rs.6.65, marking a significant nadir after a sustained downtrend spanning ten consecutive sessions and a cumulative loss of 44.39%. The stock also recorded an all-time low closing price of Rs.7.48, down 69.34% from its 52-week high of Rs.24.40. Despite a modest intraday uptick of 2.19%, the stock’s valuation remained deeply discounted relative to peers and historical levels.
The broader market was weak, with the Sensex closing down 2.29% at 32,182.38, reflecting a challenging environment. Technical indicators for the stock were bearish, trading below all major moving averages and signalling continued downward momentum. Delivery volumes surged by over 200% month-on-month, indicating heightened trading activity amid the price decline.
Fundamentally, the company’s average Return on Equity (ROE) stood at a modest 1.43%, with a low MarketsMOJO Mojo Score of 32.0 and a current Mojo Grade of Sell, upgraded from Strong Sell earlier in March. Despite weak profitability, the company demonstrated positive quarterly results, with the highest PBDIT reaching Rs.1.73 crore and an operating profit to net sales ratio of 9.95%.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
1 April 2026: Sharp Rebound on Improved Market Sentiment
The stock rebounded sharply on 1 April, gaining 9.49% to close at Rs.7.50 on relatively low volume of 17,841 shares. This recovery coincided with a strong Sensex rally of 1.97%, closing at 32,814.97. The bounce followed the prior day’s lows and was supported by the stock’s attractive valuation metrics, including a price-to-book value of 0.2 and a PEG ratio of 0.1, signalling undervaluation relative to earnings growth.
Technical momentum began to shift as the stock moved closer to key resistance levels, though it remained below all major moving averages. The improved quarterly profitability and positive earnings growth of 95.7% over the past year provided a fundamental underpinning for the rally.
2 April 2026: Continued Rally with 10.00% Gain
On 2 April, Deccan Health Care Ltd extended its gains by 10.00%, closing at Rs.8.25, the highest level for the week. The Sensex was largely flat, up 0.08% at 32,839.65, indicating the stock’s outperformance was driven by company-specific factors rather than broad market moves.
The rally reflected growing investor interest in the company’s improving financial metrics, including a quarterly profit after tax of Rs.1.00 crore and earnings per share of Rs.0.40. Despite the positive momentum, the stock remained below critical moving averages, suggesting cautious optimism among market participants.
Holding Deccan Health Care Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Weekly Price Performance: Deccan Health Care Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-30 | Rs.6.85 | -6.42% | 32,182.38 | -2.29% |
| 2026-04-01 | Rs.7.50 | +9.49% | 32,814.97 | +1.97% |
| 2026-04-02 | Rs.8.25 | +10.00% | 32,839.65 | +0.08% |
Key Takeaways from the Week
Positive Signals: The stock’s 12.70% weekly gain significantly outpaced the Sensex’s 0.29% decline, signalling a potential technical and fundamental turnaround. Improved quarterly profitability metrics, including a peak PBDIT of Rs.1.73 crore and a 9.95% operating profit to net sales ratio, underpin this recovery. The company’s valuation remains attractive, with a price-to-book value of 0.2 and a PEG ratio of 0.1, suggesting undervaluation relative to earnings growth.
Cautionary Notes: Despite the rebound, the stock remains below all major moving averages and continues to trade near historic lows. The company’s long-term fundamental strength is modest, with an average ROE of 1.43% and a Mojo Grade of Sell. Market sentiment remains cautious given the prolonged downtrend and weak sector performance. Trading volumes during the rally were relatively low, indicating tentative investor conviction.
Conclusion
Deccan Health Care Ltd’s week was marked by a sharp recovery following a prolonged period of decline culminating in 52-week and all-time lows. The 12.70% gain over the week, driven by improved profitability and attractive valuation, represents a notable shift in momentum. However, the stock’s technical position remains fragile, and fundamental challenges persist. Investors should monitor whether the recent gains can be sustained amid cautious market sentiment and ongoing sector headwinds.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
